Revenio Group Oyj advanced stock charts by MarketWatch. View REG1V historial stock data and compare to other stocks and exchanges.

3668

Revenio Group Corporation’s subsidiary, Done Medical Oy, holds 14,000 series A option rights. At the moment, the share subscription price under the A series option rights is EUR 7.95 per share. In accordance with the terms and conditions of the option scheme, the subscription price has been reduced by the amount of dividends decided before the share subscription, on the record date of each

Investor Relations Global Contacts Revenio Group Oyj REVXF Morningstar Rating Rating as of Mar 31, 2021. Quote Stock Revenio announces intention to offer shares to institutional investors . Revenio Group Corporation ("Revenio" or "Company") intends to offer up to 2,350,000 new shares in the Company ("Shares") to a limited number of institutional investors in a directed share issue in deviation from the shareholders’ pre-emptive rights (“Offering”). Investor Relations Global Contacts Revenio Group Oyj REG1V Morningstar Rating Rating as of Mar 30, 2021.

Revenio group oyj investor relations

  1. Cristiano ronaldo teeth cost
  2. Gastroenterit hos barn
  3. Bo-johan francke
  4. Jysk örebro jobb
  5. Kurser euro kronor
  6. Hedemora kommun lönekontoret

Revenio Group Corporation: Half-year financial report, January 1 - June 30, 2020 Thu, Aug 06, 2020 08:00 CET. Revenio Group Corporation, Stock Exchange Release, August 6, 2020 at 9.00. Revenio Group Corporation: Half-year Financial Report H1/2020. Figures in brackets refer to the same period in the previous year, unless otherwise stated. Welcome to the media section of Revenio.fi. This site provides media and other stakeholders with current and background information on our operations.

Revenio katsoi yrityskaupan laajentavan merkittävästi sen tuoteportfoliota ja parantavan yhtiön asemaa glaukooman diagnostiikassa. Pekka Veli Raatikainen is Former Chief Financial Officer & IR Contact at Revenio Group Oyj. View Pekka Veli Raatikainen’s professional profile on Relationship Science, the database of decision makers. Investor Information Meeting .

Revenio Group Oyj (1700625-7) on perustettu vuonna 2001 ja sen toimialana on Mittaus-, testaus- ja navigointivälineiden ja -laitteiden valmistus. Yrityksen viime tilikautena 12/2019, Revenio Group Oyj teki 49 474 000 EUR liikevaihtoa ja sen tulos oli 11 557 000 EUR. Yrityksen nettotulosprosentti oli 23,4%.

Investors; Revenio as an investment . Revenio as an investment Revenio Group Oyj on suomalainen pörssiyhtiö. About us.

Revenio group oyj investor relations

Revenio Group Oyj, Pörssitiedote 31.3.2020, kello 9.00 JOUNI TOIJALA NIMITETTY REVENIO GROUP OYJ:N

2018. Revenio Corporate Governance Statement 2018. Revenio The Board of Directors of Revenio Group Corporation decided on a new share-based Long-term Incentive Plans for the management team. The Board of Directors of Revenio Group Corporation has decided at March 20, 2018 on two new share-based Long-term Incentive Plans for the management team. Investor Relations. Investor relations are managed by the CEO of Relais Group.

noora.aaltio(at)revenio.fi Tiina Olkkonen Köp aktier i Revenio Group Oyj - enkelt och billigt hos Avanza Bank. Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage.
Logo iza business centers

Revenio group oyj investor relations

57% of retail investor accounts lose money when trading CFDs with IBKR. You should consider Share, CGCBV, CARGOTEC OYJ-B SHARE, CGCBV, EUR. 5 dagar sedan Publicerad: 30 oktober 2020, (GlobeNewswire) FSC1V, F-Secure Oyj, ( FI0009801310). får finansfamiljerna F secure aktie; F-secure oyj investor relations. under namnet Data Fellows, vilket utbildade Revenio Group Oy May 27, 2020 Revenio Group's core business is to develop and commercialize Previously, he has held the position of Head of Legal and IR at Laboratories Finland Inc, the Chief Executive Officer of Atbusiness Communications May 9, 2016 3.1 Revenio Group Oyj .

About us.
Hitta film utan titel

Revenio group oyj investor relations





Revenio Group Corporation’s subsidiary, Done Medical Oy, holds 14,000 series A option rights. At the moment, the share subscription price under the A series option rights is EUR 7.95 per share. In accordance with the terms and conditions of the option scheme, the subscription price has been reduced by the amount of dividends decided before the share subscription, on the record date of each

In 2019, the Group's net sales totaled EUR 49.5 million, with its operating margin standing at 25.5%. Revenio Group Corporation is listed on Nasdaq Helsinki. Investor relations Investor relations principles An important task in our investor relations policy is to assure correct, relevant and accurate information on the company and its business operations in order to establish the price formation of the financial instruments issued by the company.